Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,450.00    -50.00 (-0.91%)
Bid:
5,400.00
Ask:
5,450.00
Spread: 50.00 (0.926%)
Market Cap: £137.76m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Interim Management Statement

26 Mar 2009 14:20

RNS Number : 5525P
Camellia PLC
26 March 2009
 



Camellia Plc

Interim Management Statement

26 March 2009 

Interim Management Statement 

This statement is made in accordance with Rule 4.3 of the UK Listing Authority's Disclosure and Transparency Rules and covers the period from 1 January 2009 to 26 March 2009.

Dry weather is affecting the group's tea operations in both Bangladesh and the Dooars and Darjeeling areas of India and whilst this may affect our crop, tea prices have so far remained firm. The recent mutiny by the border defence force in Bangladesh did not affect our operations and it is to be hoped that the newly elected government will be able to maintain stability. In India, there has been some political unrest in the Dooars but of more concern is the effect that any upsurge in activity by those demanding statehood in Darjeeling might have on our gardens in that area.

Kenya also suffered from dry weather but there and in Malawi tea prices have remained firm. The political situation in both Kenya and Malawi remains a cause for concern with an election due to take place in Malawi in May 2009.

The group's UK engineering operations have had a mixed start to 2009 with some units, as might be expected, experiencing a reduction in orders although opportunities for new business continue to arise. 

Duncan Lawrie will find it challenging to generate income in the current environment of low interest rates and falling stock market values. The bank continues to operate on a conservative basis.

Earlier this month, our associate company, Siegfried Holding AG, announced their results for the year to 31 December 2008. These results included an impairment provision of CHF97 million in respect of goodwill and non-financial assets resulting in a net loss for the year of CHF74.8 million. However, this has not had a negative effect on the book value of the group's investment in Siegfried because of the fall in the value of sterling. Siegfried continues to operate in a very competitive marketplace in the pharmaceutical industry and has recently announced the appointment of a new Chief Executive Officer.

Two of the group's UK final salary pension schemes are currently undergoing triennial actuarial valuations, the results of which are likely to show significant increases in the schemes' deficits.

Camellia Plc will announce its results for the year ended 31 December 2008 on 28 April 2009.

For further enquiries please contact Camellia Plc 

Malcolm Perkins, Chairman 

01622 746655

26 March 2009 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSJFMITMMBTBLL
Date   Source Headline
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20258:29 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTrading Update
27th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
17th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSDirector/PDMR Shareholding
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSDisposal
5th Dec 20247:00 amRNSDisposal
11th Nov 20248:06 amRNSSale of Bangladesh associate companies
31st Oct 202411:37 amRNSDisposal
25th Oct 202412:51 pmRNSHolding(s) in Company
17th Oct 20247:00 amRNSTrading Statement
6th Sep 202411:44 amRNSInterim Report 2024
6th Sep 20247:00 amRNSHalf-year Report
1st Jul 20247:00 amRNSDirector Changes
28th Jun 20241:00 pmRNSUpdate on BF&M Transaction
7th Jun 202411:14 amRNSResult of AGM
6th Jun 20247:00 amRNSTrading Update
1st May 202412:30 pmRNSAnnual Report & Notice of Annual General Meeting
29th Apr 20247:00 amRNSFinal Results
25th Apr 20247:00 amRNSDirector Changes
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.